| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0019 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |